# Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen

> **NCT01061853** · PHASE3 · TERMINATED · sponsor: **University Hospital, Tours** · enrollment: 76 (actual)

## Conditions studied

- Oral Lichen Planus

## Interventions

- **DRUG:** TOPICAL SIROLIMUS (RAPAMUNE*)
- **DRUG:** TOPICAL BETAMETHASONE 0.05%

## Key facts

- **NCT ID:** NCT01061853
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** Per protocol intermediate analyses of 76 patients and enrollment difficulties.
- **Last updated:** 2013-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061853, "Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01061853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*